By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3388 Mike Collins Drive

Eagan  Minnesota  55121  U.S.A.
Phone: 651-675-0300 Fax: 651-675-0400


Biothera Pharmaceuticals, Inc. is advancing Imprime PGG, a unique cancer immunotherapy, through Phase 2 clinical trials in multiple cancer indications. While cancers can actively avoid detection by the immune system, Imprime PGG works like an immunological “ignition switch” to activate a host of anti-tumor immune system responses. These robust, coordinated responses can enhance the therapeutic efficacy of tumor-targeting, anti-angiogenic and immune checkpoint inhibitor antibodies.




CEO: Barry Labinger

CMO: José Iglesias, MD

CSO: Jeremy Graff, PhD

CFO: Steve Karel


Please click here for Biothera job opportunities.


Key Statistics

Ownership: Private

Web Site: Biothera


Company News
Clinical Data Support Mechanism Of Action And Patient Selection Biomarker For Imprime PGG, Biothera's Phase II Cancer Immunotherapy 9/27/2016 8:27:34 AM
Biothera Expands Relationship With Merck & Co. (MRK), Enters Collaboration For Combination Cancer Immunotherapy Trials In Multiple Indications 8/24/2016 10:50:14 AM
Biothera To Present At The Canaccord Genuity Growth Conference 8/3/2016 11:10:19 AM
Biothera Presents New Cancer Immunotherapy Research At The 2016 AACR Annual Meeting 4/19/2016 1:07:15 PM
Biothera Announces Presentations at Upcoming AACR Annual Meeting 3/17/2016 11:12:51 AM
Biothera Announces Imprime PGG Positive Safety Findings And Pharmacokinetic Data From Two Phase 1 Studies, As Published In Investigational New Drugs: The Journal Of New Anticancer Agents 2/25/2016 10:30:59 AM
Biothera’s Imprime PGG And Anti-Angiogenic Antibodies Work In Concert To Re-Orient The Immune Microenvironment To Support Cancer Killing, Study Finds 11/6/2015 8:09:11 AM
Biothera's Imprime PGG And Monoclonal Antibody Therapy Alleviates Immune Suppression In Tumor Microenvironment And Increases Cancer Cell Killing 11/6/2015 8:08:12 AM
Biothera To Present Three Abstracts At AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/2/2015 10:00:27 AM
Biothera Appoints Dr. Jose Iglesias As Chief Medical Officer 10/15/2015 10:57:49 AM